Internal Medicine, Gastroenterology · Yuba City, CA
NPI
1265504583
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
870 Shasta St Ste 200
Yuba City, CA, 95991
Phone (530) 671-3671
Groups this clinician bills Medicare through
Medicare paid, 2024
$232K
3,757 services
Medicare patients, 2024
865
Average age 72
Drug cost, 2024
$1.4M
2,676 prescriptions
Company payments, 2025
$4,491
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alexander P Kim was code 88305 (surgical pathology examination), 1,178 times for 364 patients. In total Alexander P Kim billed 3,757 services in 34 codes, and Medicare paid $232K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-09-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 88305 Surgical Pathology Examination | Office | 1,178 | 364 | $29.57 | $35K |
| 99213 Office E&M - Established | Office | 641 | 448 | $65.17 | $42K |
| G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 451 | 431 | $3.83 | $1,728 |
| 99214 Office E&M - Established | Office | 264 | 237 | $94.54 | $25K |
| 99203 Office E&M - New | Office | 224 | 224 | $67.30 | $15K |
| 45380 Lower GI Endoscopy - Other | Facility | 205 | 205 | $134.30 | $28K |
| 43239 Upper GI Endoscopy | Facility | 185 | 180 | $73.73 | $14K |
| 45385 Colonoscopy - Lesion Removal | Facility | 124 | 124 | $208.16 | $26K |
| 99204 Office E&M - New | Office | 110 | 110 | $102.75 | $11K |
| 88312 Surgical Pathology Examination | Office | 62 | 34 | $72.90 | $4,520 |
| 43235 Upper GI Endoscopy | Facility | 54 | 49 | $72.03 | $3,890 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 51 | 51 | $181.63 | $9,263 |
| 43450 Digestive/Gastrointestinal | Facility | 49 | 43 | $32.68 | $1,601 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 29 | 29 | $181.95 | $5,277 |
| 45378 Lower GI Endoscopy - Other | Facility | 28 | 27 | $129.90 | $3,637 |
By year: 2022 $243K for 4,173 services; 2023 $219K for 3,728 services; 2024 $232K for 3,757 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88305 Surgical Pathology Examination | 1,178 | 364 | $29.57 | $35K |
| 88312 Surgical Pathology Examination | 62 | 34 | $72.90 | $4,520 |
Medicare prescription drug claims, 2024
In 2024, the drug Alexander P Kim prescribed most often to Medicare patients was Omeprazole, with 534 prescriptions and refills. In total Alexander P Kim wrote 2,676 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 534 | 1,410 | 180 | $6,299 |
| Pantoprazole Sodium Generic | 456 | 1,112 | 148 | $7,526 |
| Linzess Linaclotide | 157 | 299 | 50 | $165K |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 114 | 114 | 110 | $7,116 |
| Famotidine Generic | 81 | 171 | 26 | $855 |
| Peg 3350-Electrolyte Sodium Chloride/Nahco3/Kcl/Peg | 75 | 75 | 67 | $1,620 |
| Ondansetron Odt Ondansetron | 69 | 109 | 37 | $3,534 |
| Mesalamine Er Mesalamine | 66 | 133 | 19 | $30K |
| Sucralfate Generic | 58 | 104 | 32 | $1,912 |
| Creon Lipase/Protease/Amylase | 57 | 82 | 13 | $264K |
| Esomeprazole Magnesium Generic | 56 | 166 | 18 | $4,497 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 55 | 55 | 55 | $784 |
| Dicyclomine Hcl Generic | 51 | 87 | 21 | $1,110 |
| Buspirone Hcl Generic | 51 | 117 | 15 | $1,610 |
| Peg-3350 And Electrolytes Peg3350/Sod Sulf,bicarb,cl/Kcl | 46 | 46 | 45 | $620 |
Brand drugs: 581 claims; generic drugs: 2,095 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alexander P Kim $4,491 ($4,491 in general payments such as food, travel and fees) from 19 companies. The largest payer was Abbvie Inc. with $879.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 63 | $879 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 26 | $680 |
| Madrigal Pharmaceuticals MDGL | 22 | $637 |
| Janssen Biotech, Inc. JNJ | 14 | $401 |
| Genzyme Corporation SNY | 12 | $312 |
| Lilly USA, LLC LLY | 10 | $241 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 12 | $239 |
| Ardelyx, Inc. ARDX | 13 | $224 |
| Aimmune Therapeutics, Inc. | 10 | $222 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 8 | $173 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.